CARRA
CARRA, or the CARRA Group, is a prominent player in the US healthcare industry, headquartered in the United States. Founded in 2000, the company has established itself as a leader in providing innovative solutions for clinical research and patient care, particularly in the realm of rheumatology. With a focus on advancing treatment options and improving patient outcomes, CARRA has developed a range of unique services that cater to both healthcare professionals and patients. Operating primarily across the United States, CARRA has achieved significant milestones, including the establishment of a comprehensive network of clinical sites and partnerships with leading research institutions. Their commitment to excellence is reflected in their robust data collection and analysis capabilities, which set them apart in the competitive landscape. CARRA's dedication to advancing medical knowledge and improving healthcare delivery has solidified its position as a trusted authority in the field.
DitchCarbon Score
How does CARRA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CARRA's score of 10 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
CARRA's reported carbon emissions
In 2023, CARRA reported total carbon emissions of approximately 102,000 kg CO2e from Scope 2, 26,700 kg CO2e from Scope 1, and 16,900 kg CO2e from Scope 3. This reflects a significant increase in emissions compared to 2022, where emissions were about 49,800 kg CO2e for Scope 2, 25,200 kg CO2e for Scope 1, and 16,300 kg CO2e for Scope 3. In 2021, CARRA's emissions were approximately 28,500 kg CO2e for Scope 2, 14,400 kg CO2e for Scope 1, and 10,300 kg CO2e for Scope 3. The data indicates a trend of increasing emissions over the years, particularly in Scope 2 emissions. Despite the rising emissions, CARRA has not disclosed any specific reduction targets or initiatives as part of their climate commitments. The absence of documented reduction strategies suggests a need for enhanced focus on sustainability practices within the organisation.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 14,400 | 00,000 | 00,000 |
| Scope 2 | 28,500 | 00,000 | 00,000 |
| Scope 3 | 10,300 | 00,000 | 00,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
CARRA is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
